Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

For example, RA may cause scarring on the lungs that makes it hard to breathe. Psoriatic arthritis (PsA) is an inflammatory ...

Some studies have said that people with psoriatic arthritis have similar genetic mutations. Early Tell-tale Signs Of Kidney ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Psoriasis is a common, chronic inflammatory dermatosis, and patients with psoriasis often develop nail involvement. It is ...

Considering taking supplements to treat psoriatic arthritis? Below is a list of common natural remedies used to treat or reduce the symptoms of psoriatic arthritis. Follow the links to read common ...

In the trials, a significantly greater proportion of Sotyktu -treated patients achieved ACR20 response (at least a 20 percent improvement in signs ... said, "Psoriatic arthritis is a heterogenous ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.